Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
GFL Environmental $650 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
Veeco Instruments $230 million convertible senior notes offering
The 2.875% convertible senior notes are due 2029
Oleoducto Central $100 million tender offer
The company purchased certain debt securities
LyondellBasell $500 million inaugural green bond offering
The investment-grade notes are due 2033
Toyota Motor Credit $2 billion notes offering
We advised the company on the SEC-registered notes offering
Coherus BioSciences $57.5 million follow-on offering
The stock is listed on the Nasdaq Global Market
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
Texas Instruments $1.6 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Monitronics International chapter 11 filing and DIP financing
We are advising the ad hoc lender group that is backstopping the restructuring